Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 22 (2), 6

The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care

Affiliations
Review

The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care

Jonathan A Beard et al. Curr Gastroenterol Rep.

Abstract

Purpose of review: To examine the quantifiable economic impact of inflammatory bowel disease (IBD), key cost drivers and determinants, and the impact of value-based care in IBD. Finally, we prognosticate on future directions and opportunities on healthcare economics in IBD.

Recent findings: New value-based initiatives, technologically driven interventions, and quality improvement programs have demonstrated reductions in healthcare utilization and enhanced patient outcomes, and several have realized cost of care reductions. IBD is a costly, chronic illness with unbalanced spending by a small proportion of individuals. Pharmaceutical costs are overtaking inpatient expenses as the primary cost driver. Value-based care initiatives including the IBD medical home, remote monitoring platforms such as myIBDcoach and Project Sonar, and learning healthcare networks exemplified by ImproveCareNow have all demonstrated successes in improving care quality, patient outcomes, and reduced healthcare spending in some populations. The future of value-based care in IBD is bright, with ample opportunities for model refinement, collaboration, and growth.

Keywords: Biologics; Cost; Donabedian; Inflammatory bowel disease; Patient-centered medical home; Quality; Specialty medical home; Value-based care.

Similar articles

See all similar articles

References

    1. J Crohns Colitis. 2018 Mar 28;12(4):408-418 - PubMed

References

    1. J Clin Gastroenterol. 2006 Mar;40(3):200-8 - PubMed

References

    1. Can J Gastroenterol Hepatol. 2014 May;28(5):275-85 - PubMed

References

    1. Inflamm Bowel Dis. 2011 Jan;17(1):450-7 - PubMed

References

    1. Arch Med Sci. 2016 Apr 1;12(2):295-302 - PubMed

References

    1. Scand J Gastroenterol. 2008 Aug;43(8):948-54 - PubMed

References

    1. Milbank Q. 2005;83(4):691-729 - PubMed

References

    1. Res Social Adm Pharm. 2017 May - Jun;13(3):530-538 - PubMed

References

    1. Can J Gastroenterol. 2012 Nov;26(11):811-7 - PubMed

References

    1. J Gastrointest Surg. 2018 Jan;22(1):124-132 - PubMed

References

    1. Am J Gastroenterol. 2012 Aug;107(8):1228-35 - PubMed

References

    1. Health Aff (Millwood). 2014 Jul;33(7):1123-31 - PubMed

References

    1. Clin Gastroenterol Hepatol. 2017 Mar;15(3):385-392.e2 - PubMed

References

    1. Dig Dis Sci. 2020 Jan;65(1):96-103 - PubMed

References

    1. J Clin Gastroenterol. 1992 Jun;14(4):309-17 - PubMed

References

    1. J Med Internet Res. 2019 Jun 03;21(6):e14165 - PubMed

References

    1. Inflamm Bowel Dis. 2010 May;16(5):830-5 - PubMed

References

    1. Clin Gastroenterol Hepatol. 2017 Aug;15(8):1148-1153.e4 - PubMed

References

    1. Clin Gastroenterol Hepatol. 2007 Dec;5(12):1430-8 - PubMed

References

    1. Am J Gastroenterol. 2019 Mar;114(3):472-482 - PubMed

References

    1. Inflamm Bowel Dis. 2015 Mar;21(3):615-22 - PubMed

References

    1. Public Health. 2006 Nov;120(11):1002-7 - PubMed

References

    1. Gut. 2014 Oct;63(10):1607-16 - PubMed

References

    1. Am J Gastroenterol. 2017 Feb;112(2):325-336 - PubMed

References

    1. N C Med J. 2016 Jul-Aug;77(4):276-8 - PubMed

References

    1. Inflamm Bowel Dis. 2016 Jun;22(6):1442-9 - PubMed

References

    1. Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):720-7 - PubMed

References

    1. J Crohns Colitis. 2014 Mar;8(3):240-51 - PubMed

References

    1. Clin Gastroenterol Hepatol. 2018 Nov;16(11):1777-1785 - PubMed

References

    1. Aliment Pharmacol Ther. 2008 Jul;28(1):76-87 - PubMed

References

    1. Scand J Gastroenterol. 2009;44(4):431-40 - PubMed

References

    1. Lancet. 2017 Sep 2;390(10098):959-968 - PubMed

References

    1. Dig Dis Sci. 2018 Jun;63(6):1392-1408 - PubMed

References

    1. Aliment Pharmacol Ther. 2010 Apr;31(7):693-707 - PubMed

References

    1. Intest Res. 2018 Jan;16(1):43-47 - PubMed

References

    1. Gastroenterology. 1999 Jul;117(1):49-57 - PubMed

References

    1. N Engl J Med. 2010 Dec 23;363(26):2477-81 - PubMed

References

    1. Am J Gastroenterol. 2000 Aug;95(8):1955-60 - PubMed

References

    1. Inflamm Bowel Dis. 2019 Sep 18;25(10):1718-1728 - PubMed

References

    1. Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30 - PubMed

References

    1. Gut. 2012 Apr;61(4):622-9 - PubMed

References

    1. Am J Gastroenterol. 2016 Jan;111(1):15-23 - PubMed

References

    1. Lancet. 2018 Dec 23;390(10114):2769-2778 - PubMed

References

    1. JAMA. 2012 Apr 11;307(14):1513-6 - PubMed

References

    1. Aliment Pharmacol Ther. 2012 Nov;36(9):840-9 - PubMed

References

    1. Inflamm Bowel Dis. 2013 Mar;19(3):662-8 - PubMed

References

    1. Aliment Pharmacol Ther. 2009 Aug;30(3):265-74 - PubMed

References

    1. Inflamm Bowel Dis. 2016 Aug;22(8):1971-80 - PubMed

References

    1. Gastroenterology. 2008 Dec;135(6):1907-13 - PubMed

LinkOut - more resources

Feedback